Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs Apixaban for VTE Prophylaxis After Hysterectomy
IRCT20260801070476N1Phase 4Recruiting
- Sponsor
- Kerman University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in venous thromboembolism (VTE) comparing Enoxaparin arm with Apixaban arm (2 arms). Primary endpoint: Incidence of venous thromboembolism. Started Aug 2026; status: recruiting.
02
Drugs
enoxaparinapixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20260801070476N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260801070476N1.